Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Qvarfordt (Uppsala, Sweden), M. Anderson (Stockholm, Sweden), A. Sanchez-Crespo (Stockholm, Sweden), M. Diakopoulou (Stockholm, Sweden), M. Svartengren (Uppsala, Sweden). A comparison of 99mTc-DTPA clearance and translocation of nano particles in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.. 3162

Member's Comments

No comment yet.

Related content which might interest you: Patients with idiopathic pulmonary fibrosis and chronic obstructive lung disease leak inhaled nanoparticles to the blood. Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Immunological profiling of chronic obstructive airways disease and idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Relationship between emphysema extent and pulmonary function test in chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema Source: Eur Respir J 2011; 37: 176-183 Year: 2011 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Emphysema and carbonmonoxide diffusion capacity in male chronic obstructive pulmonary disease patients Source: Annual Congress 2009 - Imaging of COPD, asthma and emphysema in evolution Year: 2009 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Mucociliary system in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 58s Year: 2004 Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 An early prediction of intravascular microthromb formation for patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Disease of the airways in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 41S-49S Year: 2001 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Large airways remodeling in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Noninvasive ventilation in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis Source: Eur Respir J 2002; 20: 777-784 Year: 2002